Federal award
BECKMAN COULTER, INC
W81K0023P0166
Contract
Obligated and Ceiling
- Obligated (net)
- $406,967.54
- Ceiling (potential value, not spending)
- $834,117.63
- Current value
- $667,294.11
- Gross positive obligations
- $516,562.68
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- BECKMAN COULTER, INC · PU6HHX2R11C7
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- BECKMAN COULTER, INC · PU6HHX2R11C7
- Awarding agency
- Department of War · sub-agency 2100 · office W81K00
- Funding agency
- Department of War · sub-agency 97DH
- Product or service (PSC)
- 6505 · DRUGS AND BIOLOGICALS
- Industry (NAICS)
- 325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
- PIID
- W81K0023P0166
- Award type code
- B
- Actions
- 9 · Jul 11, 2023 to Jun 24, 2026
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History9
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Jun 24, 2026 | FY2026 | P00008 | G | $0.00 | — |
| Feb 6, 2026 | FY2026 | P00007 | C | −$93,503.05 | — |
| Dec 22, 2025 | FY2026 | P00006 | C | $166,823.52 | — |
| Jun 18, 2025 | FY2025 | P00005 | G | $0.00 | — |
| Dec 23, 2024 | FY2025 | P00004 | C | $166,823.52 | — |
| Mar 28, 2024 | FY2024 | P00003 | G | $0.00 | — |
| Feb 28, 2024 | FY2024 | P00002 | B | −$16,092.09 | — |
| Nov 14, 2023 | FY2024 | P00001 | C | $182,915.64 | — |
| Jul 11, 2023 | FY2023 | 0 | — | $0.00 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.